Meltem Taşbakan

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanrıöver, Levent Doğanay, Murat Akova et al. · The Lancet · 2021 · 929 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections

Hüsnü Pullukçu, Meltem Taşbakan, Oğuz Reşat Sipahi et al. · International Journal of Antimicrobial Agents · 2006 · 168 citations

Life Sciences, Microbiology, Pharmacology +10

The course of spinal tuberculosis (Pott disease): results of the multinational, multicentre Backbone-2 study

Hakan Erdem, Gönül Şengöz, Ergys Ramosaço et al. · Clinical Microbiology and Infection · 2015 · 96 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +8

Carbapenem Versus Fosfomycin Tromethanol in the Treatment of Extended-Spectrum Beta-Lactamase-Producing<i>Escherichia Coli</i>-Related Complicated Lower Urinary Tract Infection

Meltem Taşbakan, Hüsnü Pullukçu, Oğuz Reşat Sipahi et al. · Journal of Chemotherapy · 2010 · 78 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Did the pandemic have an impact on influenza vaccination attitude? a survey among health care workers

Bilgin Arda, Raika Durusoy, Tansu Yamazhan et al. · BMC Infectious Diseases · 2011 · 78 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +16